Visual Function After Implantation of Bilateral AcrySof ReSTOR Aspheric +3

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

218 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-09-30

Study Completion Date

2009-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A prospective evaluation of the visual parameters in a series of patients bilaterally implanted with AcrySof ReSTOR +3 Intraocular Lens (IOL).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Visual Performance of Bilateral AcrySof ReSTOR Aspheric +4

NCT01215045

Cataract

COMPLETED

Visual Function After Implantation of Bilateral AcrySoft ReSTOR Aspheric IOL

NCT00934622

Cataract

COMPLETED PHASE4

Visual Function With Bilateral AcrySof® ReSTOR® Aspheric SN6AD1

NCT00710931

Cataract

COMPLETED PHASE4

Visual Function Evaluation of Bilateral AcrySof ReSTOR Aspheric IOL

NCT00818116

Cataracts

COMPLETED PHASE4

Visual Outcomes of Subjects Bilaterally Implanted With ReSTOR Aspheric +4 vs. Tecnis or Acri.LISA

NCT00721253

Cataract

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ReSTOR Aspheric +3

Enrolled subjects receive implantation of ReSTOR +3 intraocular lenses (IOLs) for replacement of cataract in the natural lens of the eye. The patients were to be implanted bilaterally (in both eyes).

Group Type EXPERIMENTAL

ReSTOR

Intervention Type DEVICE

Enrolled subjects receive implantation of ReSTOR +3 intraocular lenses (IOLs) for replacement of cataract in the natural lens of the eye. The patients were to be implanted bilaterally (in both eyes).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ReSTOR

Enrolled subjects receive implantation of ReSTOR +3 intraocular lenses (IOLs) for replacement of cataract in the natural lens of the eye. The patients were to be implanted bilaterally (in both eyes).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with cataracts

Exclusion Criteria

* Pre-existing conditions that could skew the results or are contraindications for the ReSTOR intraocular lens;
* \<1 diopter astigmatism by keratometry readings.

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes